Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | March 03, 2025 | March 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date March 03, 2025 · Filed March 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,259 |
Ending reported balance
After 2025-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-03 · Sale · Disposed 2,236 · Balance 8,970 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2025-03-03 · Sale · Disposed 1,233 · Balance 7,737 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2025-03-03 · Sale · Disposed 478 · Balance 7,259 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectHeld by son | 167 |
Reported balance
Holding disclosure · report date 2025-03-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 167 |
| Common StockSEC Table I · non-derivative | IndirectHeld by daughter | 166 |
Reported balance
Holding disclosure · report date 2025-03-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 166 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2023 Filed Feb 15, 2023 00:55 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022082 · tm236006-7_4seq1.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,090 Underlying: Common Stock · 10,000 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 156 | $255.98 | $39,932.88 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.97 to $256.00, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,056 | $253.79 | $268,002.24 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.41 to $254.2966, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,788 | $252.71 | $957,265.48 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,516 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.26 to $253.16, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,600 | $251.64 | $654,264.00 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,304 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.22 to $252.15, inclusive. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,400 | $250.62 | $601,488.00 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,904 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.09 to $251.05, inclusive. F4 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,000 | $0.94 | $9,400.00 |
DisclosureSEC source: 0001104659-23-001570 · tm232257-1_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 6, 2022. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,149 | $239.16 | $274,794.84 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285 F2 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.66 to $239.60. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,400 | $238.05 | $333,270.00 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434 F2 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.60 to $238.54. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 642 | $236.64 | $151,922.88 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,834 F2 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.24 to $237.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,954 | $235.29 | $459,756.66 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,476 F2 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.11 to $236.24. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,188 | $234.68 | $1,217,519.84 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,430 F2 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.11 to $235.05. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · derivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,090 Underlying: Common Stock · 5,000 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,333 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 5,333 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,333 | $0.94 | $9,713.02 |
DisclosureSEC source: 0001104659-22-124890 · tm2232063d1_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 6, 2022. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,924 | $0.00 Strike: $227.53 | $0.00 |
DisclosureSEC source: 0001104659-22-023827 · tm226817-5_4seq1.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,924 Underlying: Common Stock · 5,924 shares Expires 2032-02-11 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,532 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · derivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,532 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,532 | $244.67 | $864,174.44 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,532 | $2.07 | $7,311.24 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,740 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,533 Underlying: Common Stock · 1,740 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,035 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · derivative · entry 8 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,532 Underlying: Common Stock · 5,035 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 6,775 | $240.00 | $1,626,000.00 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,740 | $0.94 | $1,635.60 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,035 | $2.07 | $10,422.45 |
DisclosureSEC source: 0001104659-22-001912 · tm221891-1_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 18 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 28, 2021. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 772 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · derivative · entry 12 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,273 Underlying: Common Stock · 772 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 646 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · derivative · entry 11 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,567 Underlying: Common Stock · 646 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,418 | $240.00 | $340,320.00 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 772 | $0.94 | $725.68 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 646 | $2.07 | $1,337.22 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,488 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · derivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,045 Underlying: Common Stock · 5,488 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. F4 · derivative.expiration_date: This option grant was previously reported as having an expiration date of December 31, 2026, which has been revised herein. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,854 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,213 Underlying: Common Stock · 2,854 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 8,342 | $240.00 | $2,002,080.00 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,488 | $0.94 | $5,158.72 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,854 | $2.07 | $5,907.78 |
DisclosureSEC source: 0001104659-21-153990 · tm2136468-1_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 6, 2021. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,187 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · derivative · entry 14 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,187 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · derivative · entry 13 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,067 Underlying: Common Stock · 15,000 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 50 | $187.26 | $9,363.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 300 | $186.11 | $55,833.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.04 to $186.17. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,508 | $185.51 | $465,259.08 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 8 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.01. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,522 | $184.57 | $280,915.54 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,087 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.01 to $184.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,374 | $183.31 | $251,867.94 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,609 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.01 to $183.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 8,326 | $182.36 | $1,518,329.36 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,983 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.01 to $182.92. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 8,760 | $181.55 | $1,590,378.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,309 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.01 to $182.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 7,347 | $180.55 | $1,326,500.85 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,069 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 15,187 | $1.14 | $17,313.18 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 15,000 | $2.07 | $31,050.00 |
DisclosureSEC source: 0001104659-21-001569 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 40 additional shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on September 11, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 17,300 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-20-136410 · a4.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Underlying: Common Stock · 17,300 shares Expires 2030-12-14 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-20-104418 · a4.xml · derivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,187 Underlying: Common Stock · 30,000 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,192 | $119.99 | $622,988.08 |
DisclosureSEC source: 0001104659-20-104418 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.